Auburn Pharmaceutical Company
Auburn Pharmaceutical Company, often referred to simply as Auburn Pharma, is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 2005, the company has made significant strides in developing innovative healthcare solutions, particularly in the fields of pain management and anaesthesia. With a strong operational presence across North America and Europe, Auburn Pharma is renowned for its unique formulations and commitment to quality. The company’s core products include a range of injectable medications that stand out for their efficacy and safety profiles. Auburn Pharmaceutical Company has achieved notable recognition within the industry, positioning itself as a trusted partner for healthcare providers. Its dedication to research and development continues to drive advancements in patient care, solidifying its reputation as a leader in pharmaceutical innovation.
DitchCarbon Score
How does Auburn Pharmaceutical Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Auburn Pharmaceutical Company's score of 13 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Auburn Pharmaceutical Company's reported carbon emissions
Auburn Pharmaceutical Company, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and climate commitments. This includes efforts to reduce greenhouse gas emissions across all scopes—Scope 1 (direct emissions), Scope 2 (indirect emissions from energy), and Scope 3 (indirect emissions from the supply chain). As the industry evolves, stakeholders are encouraged to monitor Auburn Pharmaceutical Company's future commitments and initiatives related to carbon emissions and climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Auburn Pharmaceutical Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
